Bridgeway Capital Management’s TherapeuticsMD TXMD Stock Holding History

Bridgeway Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.6K	Hold	17,000	–	–	﹤0.01%	1214
2026 Q1	$34.3K	Hold	17,000	–	–	﹤0.01%	1198
2025 Q4	$27.7K	Sell	17,000 -17,000	-50%	-$24.6K	﹤0.01%	1202
2025 Q3	$36K	Hold	34,000	–	–	﹤0.01%	1178
2025 Q2	$39.4K	Hold	34,000	–	–	﹤0.01%	1142
2025 Q1	$31.4K	Hold	34,000	–	–	﹤0.01%	1141
2024 Q4	$29.2K	Hold	34,000	–	–	﹤0.01%	1175
2024 Q3	$56.4K	Hold	34,000	–	–	﹤0.01%	1204
2024 Q2	$54.7K	Sell	34,000 -5,100	-13%	-$10.3K	﹤0.01%	1207
2024 Q1	$89.5K	Sell	39,100 -2,900	-7%	-$6.71K	﹤0.01%	1218
2023 Q4	$94.5K	Hold	42,000	–	–	﹤0.01%	1250
2023 Q3	$127K	Hold	42,000	–	–	﹤0.01%	1179
2023 Q2	$173K	Hold	42,000	–	–	﹤0.01%	1168
2023 Q1	$158K	Hold	42,000	–	–	﹤0.01%	1148
2022 Q4	$235K	Buy	42,000 +27,000	+180%	+$159K	0.01%	1051
2022 Q3	$100K	Buy	+15,000	New	+$121K	﹤0.01%	1267
2021 Q1	–	Sell	-5,510	Closed	-$333K	–	1413
2020 Q4	$333K	Hold	5,510	–	–	0.01%	1089
2020 Q3	$435K	Sell	5,510 -954	-15%	-$76K	0.01%	950
2020 Q2	$404K	Buy	6,464 +1,534	+31%	+$89.3K	0.01%	929
2020 Q1	$261K	Sell	4,930 -1,168	-19%	-$116K	0.01%	973
2019 Q4	$738K	Buy	6,098 +2,058	+51%	+$296K	0.01%	817
2019 Q3	$733K	Buy	+4,040	New	+$569K	0.01%	817

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bridgeway Capital Management's TXMD Position: Q2 2026 in Review

Bridgeway Capital Management held its TherapeuticsMD (TXMD) position steady in Q2 2026 at 17,000 shares worth $37.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.

Bridgeway Capital Management first reported a position in TXMD in Q3 2019 and has held it in 22 quarters since. The position peaked at $738K in Q4 2019. 45 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

Bridgeway Capital Management held 17,000 shares of TherapeuticsMD worth $37.6K as of Q2 2026.
Bridgeway Capital Management left its TherapeuticsMD share count unchanged in Q2 2026.
TherapeuticsMD made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1214 holding.
Bridgeway Capital Management first reported a position in TherapeuticsMD in Q3 2019 and has held it in 22 quarters since.
Bridgeway Capital Management's TherapeuticsMD position peaked at $738K in Q4 2019.
45 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.